Skip to main content



Effective therapeutics are essential for keeping us healthy. But today medicine is facing a plethora of challenges, a lot of which are to do with the climate crisis: biodiversity loss has been linked to increased pathogen transmission and disease incidence, emissions kill around 7 million people every year, and extreme weather events help the spread of infectious diseases.

Not only this, but WHO predicts that by 2050, 10 million people will die each year as a result of increased antimicrobial resistance (AMR). Antimicrobials are medicines used to prevent and treat infections in humans, animals, and plants. AMR occurs when bacteria, viruses, fungi, and parasites evolve and no longer respond to medicines. Infections become harder to treat and there is increased risk of disease spread and death. New antimicrobials are urgently needed as a result.

With the development of new therapeutics, we are in a position to enable a much needed ‘revolution’ in medicine that will effectively treat patients.


The healthcare practice was founded to enable technologies that will bring about a ‘revolution’ in medicine:

  • Progressing the antimicrobial pipeline, with a focus on effectively treating infections and reducing bacterial numbers / viral loads
  • Provide the opportunity to look at medical devices and therapeutics within FemTech, to make such technologies accessible to women around the world
  • Progressing the adoption of innovative technologies, such as CRISPR-Cas9 for genomic alterations